Abstract
67MO Node-sparing modified short-course radiotherapy combined with CAPOX and tislelizumab in patients with MSS/pMMR locally advanced rectal cancer: A multicentre phase II trial (mRCAT)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have